Koninklijke Philips N.V. (PHG)
NYSE: PHG · Real-Time Price · USD
26.46
-0.16 (-0.60%)
At close: Dec 15, 2025, 4:00 PM EST
26.66
+0.20 (0.76%)
Pre-market: Dec 16, 2025, 6:07 AM EST
Koninklijke Philips Revenue
Koninklijke Philips had revenue of 4.30B EUR in the quarter ending September 30, 2025, a decrease of -1.71%. This brings the company's revenue in the last twelve months to 18.38B, up 1.90% year-over-year. In the year 2024, Koninklijke Philips had annual revenue of 18.02B, down -0.81%.
Revenue (ttm)
18.38B EUR
Revenue Growth
+1.90%
P/S Ratio
1.21
Revenue / Employee
271,014 EUR
Employees
67,823
Market Cap
25.25B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.02B | -148.00M | -0.81% |
| Dec 31, 2023 | 18.17B | 342.00M | 1.92% |
| Dec 31, 2022 | 17.83B | 671.00M | 3.91% |
| Dec 31, 2021 | 17.16B | -157.00M | -0.91% |
| Dec 31, 2020 | 17.31B | 166.00M | 0.97% |
| Dec 31, 2019 | 17.15B | -974.00M | -5.37% |
| Dec 31, 2018 | 18.12B | 341.00M | 1.92% |
| Dec 31, 2017 | 17.78B | 358.00M | 2.05% |
| Dec 31, 2016 | 17.42B | 616.00M | 3.67% |
| Dec 31, 2015 | 16.81B | -4.59B | -21.43% |
| Dec 31, 2014 | 21.39B | -599.00M | -2.72% |
| Dec 31, 2013 | 21.99B | -244.00M | -1.10% |
| Dec 31, 2012 | 22.23B | -344.00M | -1.52% |
| Dec 31, 2011 | 22.58B | 285.00M | 1.28% |
| Dec 31, 2010 | 22.29B | 2.20B | 10.95% |
| Dec 31, 2009 | 20.09B | -6.29B | -23.85% |
| Dec 31, 2008 | 26.39B | -408.00M | -1.52% |
| Dec 31, 2007 | 26.79B | 111.00M | 0.42% |
| Dec 31, 2006 | 26.68B | 1.24B | 4.86% |
| Dec 31, 2005 | 25.45B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PHG News
- 1 day ago - Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI - GlobeNewsWire
- 11 days ago - Philips CEO Warns About 2026 Growth Target, Stock Drops - Benzinga
- 11 days ago - Philips reiterates timing of 2026 outlook - GlobeNewsWire
- 14 days ago - XENOVIEW® 3T coil passes Philips compatibility testing - GlobeNewsWire
- 14 days ago - Philips expands commercial availability of world's first real-time AI-enabled light-based 3D navigation solution for image-guided therapy - GlobeNewsWire
- 15 days ago - Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision - GlobeNewsWire
- 15 days ago - Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform - GlobeNewsWire
- 21 days ago - Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere - GlobeNewsWire